Clinical Trials Browser

Phase 1/2 × Myelodysplastic-Myeloproliferative Diseases × Arsenic Trioxide × Clear all

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Clinical Trials

Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes